Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Retrospective Case Series Study of Hypomethylating Therapy in IPSS Lower-Risk Myelodysplastic Syndrome

Han-Seung Park, MD, Je-Hwan Lee, MD, Yoo-Jin Kim, Sang Kyun Sohn, MD, PhD, Sung-Soo Yoon, Hawk Kim, June-Won Cheong, MD, Won-Sik Lee, MD, Gyeong-Won Lee, MD, Young-Don Joo, MD, Min Kyoung Kim, MD, Yang Soo Kim, MD, Hyeoung-Joon Kim

Blood (2016) 128 (22): 1992.

https://doi.org/10.1182/blood.V128.22.1992.1992

Published: 2016

Journal Articles

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Blood (2015) 126 (6): 746–756.

https://doi.org/10.1182/blood-2015-03-636548

Published: 2015

Includes: Supplemental data

Journal Articles

Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma

Blood (2014) 124 (21): 4421.

https://doi.org/10.1182/blood.V124.21.4421.4421

Published: 2014

Journal Articles

Inferior Long-Term Outcome of Front-Line Hypomethylating Agent Compared to Supportive Care in Patients with Lower Risk Myelodysplastic Syndrome: Prosensity Score Matched Analysis

Sang Kyun Sohn, MD PhD, Joon Ho Moon, MD PhD, Ahn Jae Sook, MD, PhD, Hyeoung Joon Kim, MD PhD, Moo kon Song, MD, PhD, Ho-Jin Shin, MD PhD, Won Sik Lee, MD PhD, Sang Min Lee, MD PhD, Young Don Joo, MD PhD, Ho Sup Lee, Yang Soo Kim, Yoon Young Cho, MD PhD, Sung Hwa Bae

Blood (2014) 124 (21): 3255.

https://doi.org/10.1182/blood.V124.21.3255.3255

Published: 2014

Journal Articles

The Prognostic Impact of Inflammatory Factors for Survival in Patients with Newly Diagnosed Multiple Myeloma Who Were Treated with Thalidomide Containing Induction Chemotherapy Underwent Autologous Stem Cell Transplantation

Cheolsu Kim, Ho Sup Lee, Yang Soo Kim, Chang-Ki Min, Je-Jung Lee, MD PhD, Kihyun Kim, MD, Dok Hyun Yoon, MD, Hyeon Seok Eom, Hyewon Lee, MD, Won Sik Lee, MD, Ho-Jin Shin, MD, PhD, Ji Hyun Lee, Yong Park, MD PhD, Jae-Cheol Jo, MD, Young Rok Do, MD, Yeung-Chul Mun

Blood (2014) 124 (21): 5896.

https://doi.org/10.1182/blood.V124.21.5896.5896

Published: 2014

Journal Articles

The Clinical Impact of Thalidomide Maintenance on Progression Free Survival and Postrelapse Survival after Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple myeloma

Ho Sup Lee, Yang Soo Kim, Chang-Ki Min, Je-Jung Lee, MD PhD, Kihyun Kim, MD, Dok Hyun Yoon, MD, Hyeon Seok Eom, Hyewon Lee, MD, Won Sik Lee, MD, Ho-Jin Shin, MD, PhD, Ji Hyun Lee, Yong Park, MD PhD, Jae-Cheol Jo, MD, Young Rok Do, MD, Yeung-Chul Mun

Blood (2014) 124 (21): 3975.

https://doi.org/10.1182/blood.V124.21.3975.3975

Published: 2014

Journal Articles

Response Adapted Lenalidomide Based Therapy For Newly Diagnosed (ND) Standard Risk Older Adults With Multiple Myeloma (MM): An International Collaboration

Rachid Baz, MD, Hui-Yi Lin, PhD, Sung-Soo Yoon, MD, Kihyun Kim, MD, Melissa Alsina, MD, Kenneth H. Shain, MD, PhD, Dan Sullivan, MD, Hye Jin Kang, Jin Seok Kim, MD, Cheolwon Suh, Je-Jung Lee, MD, PhD, Jeong-A Kim, MD, PhD, Yang Soo Kim, MD, Chang-Ki Min, MD, Jae-Yong Kwak, MD, PhD, Sung-Hyun Kim, MD, PhD, Won Sik Lee, MD, Junshik Hong, MD, Jae Hoon Lee, MD

Blood (2013) 122 (21): 3201.

https://doi.org/10.1182/blood.V122.21.3201.3201

Published: 2013

Journal Articles

Role Of Hypomethylating Agents For Patients With Lower-Risk Myelodysplastic Syndrome Defined By IPSS and IPSS-R

Joon Ho Moon, M.D., Ph.D, Sang Kyun Sohn, MD, PhD, Jae Sook Ahn, MD, Yeo-Kyeoung Kim, MD, PhD, Hyeoung Joon Kim, MD, PhD, Moo-Kon Song, MD, Ho-Jin Shin, Joo-Seop Chung, MD, PhD, Ik Chan Song, MD, Deog-Yeon Jo, MD, PhD, Sung Nam Lim, MD, Ho Sup Lee, Yang Soo Kim, MD, PhD, Sung Hwa Bae

Blood (2013) 122 (21): 2782.

https://doi.org/10.1182/blood.V122.21.2782.2782

Published: 2013

Journal Articles

Prognostic Significance Of Systemic Inflammatory Factors In Patients With Diffuse Large B Cell Lymphoma Treated By R-CHOP

Kyung Ah Yoh, Ho Sup Lee, Lee Chun Park, MD, Eun Mi Lee, Seong Hoon Shin, MD, Byeong Jin Ye, Joon Ho Moon, M.D., Ph.D., Jae-Cheol Jo, Won Sik Lee, M.D., Ho-Jin Shin, Sun Young Oh, MD, Yang Soo Kim

Blood (2013) 122 (21): 1802.

https://doi.org/10.1182/blood.V122.21.1802.1802

Published: 2013

Journal Articles

Observational Study Of VMP (Bortezomib, melphalan, prednisolone) Regimen For Newly Diagnosed Korean Myeloma Patients Who Are Not Eligible For Transplantation

Blood (2013) 122 (21): 5379.

https://doi.org/10.1182/blood.V122.21.5379.5379

Published: 2013

Journal Articles

Nilotinib Combined With Multi-Agent Chemotherapy For Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Final Results Of Prospective Multicenter Phase 2 Study

Blood (2013) 122 (21): 55.

https://doi.org/10.1182/blood.V122.21.55.55

Published: 2013

Journal Articles

Predictive Factors for Rapid Engraftment of Neutrophil and Platelet After Allogenic Peripheral Blood Stem Cell Transplantation in Patients with Hematologic Malignancies

Ho Sup Lee, MD, Lee Chun Park, MD, Eun Mi Lee, Byeong Jin Ye, MD, Joon Ho Moon, M.D., Won Sik Lee, Ho-Jin Shin, Jooseop Chung, MD, PhD, Yang Soo Kim

Blood (2012) 120 (21): 4499.

https://doi.org/10.1182/blood.V120.21.4499.4499

Published: 2012

Journal Articles

A Retrospective Study to Evaluate the Survival Rates in R-CHOP Chemotherapy Followed by Autologous Stem Cell Transplantation for the Treatment of Diffuse Large B Cell Lymphoma

Mark H. Lee, MD., PhD., Sung-Yong Kim, MD.PhD., Inho Kim, MD, PhD, Seonyang Park, MD, PhD, Yeo-Kyeoung Kim, MD.PhD., Yang Soo Kim, MD.PhD., Ho Sup Lee, MD, Jeong-A Kim, MD.PhD., Jinny Park, MD.PhD., Seok Jin Kim, MD, PhD, Sung Kyu Park, MD.PhD., Byeong-Bae Park, MD.PhD., Hyeok Shim, MD.PhD., Hyeon Seok Eom, MD, Junglim Lee, MD

Blood (2012) 120 (21): 4517.

https://doi.org/10.1182/blood.V120.21.4517.4517

Published: 2012

Journal Articles

Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement.

Blood (2012) 120 (21): 2683.

https://doi.org/10.1182/blood.V120.21.2683.2683

Published: 2012

Journal Articles

Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Chemotherapy Followed by High-Dose Therapy with ASCT for Newly Diagnosed Multiple Myeloma; Open-Labeled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis.

Blood (2012) 120 (21): 3106.

https://doi.org/10.1182/blood.V120.21.3106.3106

Published: 2012

Journal Articles

Prognostic Significance of Elevated Serum Ferritin Before Chemotherapy in Patients with Non-Hodgkin's Lymphoma

Kyung Ah Yoh, Ho Sup Lee, MD, Lee Chun Park, MD, Eun Mi Lee, Dae Jin Park, Yang Soo Kim

Blood (2012) 120 (21): 5099.

https://doi.org/10.1182/blood.V120.21.5099.5099

Published: 2012

Journal Articles

Bortezomib Induction Followed by ASCT in Patients with Multiple Myeloma: Achievement of Response After Induction and Achieving CR Post-ASCT Are Both Important Prognostic Markers

Blood (2011) 118 (21): 1866.

https://doi.org/10.1182/blood.V118.21.1866.1866

Published: 2011

Journal Articles

Nilotinib Combined with Multi-Agent Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Interim Results of Korean Adult ALL Working Party Phase 2 Study

Blood (2011) 118 (21): 1517.

https://doi.org/10.1182/blood.V118.21.1517.1517

Published: 2011

Journal Articles

Therapeutic Comparision of Surgical Resection Followed by R-CHOP and R-CHOP Alone for Primary Localized Intestinal Diffuse Large B Cell Lymphoma

Ho Sup Lee, Lee Chun Park, MD, Eun Mi Lee, Seong Hoon Shin, MD, Byeong Jin Ye, MD, Sung Yong Oh, Moo-kon Song, Sang Min Lee, MD, Won-Sik Lee, MD, Byung Woog Kang, Myung Hee Chang, Seok-Goo Cho, Seung-Ah Yahng, Sung-Soo Yoon, MD, PhD, Ji-Hyun Kwon, Yang Soo Kim

Blood (2011) 118 (21): 1627.

https://doi.org/10.1182/blood.V118.21.1627.1627

Published: 2011

Journal Articles

Early Response to Botezomib Combined Chemotherapy Can Be Helpful for Prediction of Progression Free Survival in Patients with Multiple Myeloma Who Were Ineligible for Stem Cell Transplantation

Ho Sup Lee, Yang Soo Kim, Kihyun Kim, Jin Seok Kim, Hyo Jung Kim, MD, PhD, Chang-Ki Min, Cheolwon Suh, MD, Hyeon-Seok Eom, Sung-Soo Yoon, MD, PhD, Jae Hoon Lee, MD, Min Kyoung Kim, Sung Hyun Kim, MD, PhD, Sung Hwa Bae, Yeung-Chul Mun, Deog Yeon Jo, Joo Seop Chung

Blood (2011) 118 (21): 5138.

https://doi.org/10.1182/blood.V118.21.5138.5138

Published: 2011

NARROW

Retrospective Case Series Study of Hypomethylating Therapy in IPSS Lower-Risk Myelodysplastic Syndrome

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma

Inferior Long-Term Outcome of Front-Line Hypomethylating Agent Compared to Supportive Care in Patients with Lower Risk Myelodysplastic Syndrome: Prosensity Score Matched Analysis

The Prognostic Impact of Inflammatory Factors for Survival in Patients with Newly Diagnosed Multiple Myeloma Who Were Treated with Thalidomide Containing Induction Chemotherapy Underwent Autologous Stem Cell Transplantation

The Clinical Impact of Thalidomide Maintenance on Progression Free Survival and Postrelapse Survival after Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple myeloma

Response Adapted Lenalidomide Based Therapy For Newly Diagnosed (ND) Standard Risk Older Adults With Multiple Myeloma (MM): An International Collaboration

Role Of Hypomethylating Agents For Patients With Lower-Risk Myelodysplastic Syndrome Defined By IPSS and IPSS-R

Prognostic Significance Of Systemic Inflammatory Factors In Patients With Diffuse Large B Cell Lymphoma Treated By R-CHOP

Observational Study Of VMP (Bortezomib, melphalan, prednisolone) Regimen For Newly Diagnosed Korean Myeloma Patients Who Are Not Eligible For Transplantation

Nilotinib Combined With Multi-Agent Chemotherapy For Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Final Results Of Prospective Multicenter Phase 2 Study

Predictive Factors for Rapid Engraftment of Neutrophil and Platelet After Allogenic Peripheral Blood Stem Cell Transplantation in Patients with Hematologic Malignancies

A Retrospective Study to Evaluate the Survival Rates in R-CHOP Chemotherapy Followed by Autologous Stem Cell Transplantation for the Treatment of Diffuse Large B Cell Lymphoma

Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement.

Prognostic Significance of Elevated Serum Ferritin Before Chemotherapy in Patients with Non-Hodgkin's Lymphoma

Bortezomib Induction Followed by ASCT in Patients with Multiple Myeloma: Achievement of Response After Induction and Achieving CR Post-ASCT Are Both Important Prognostic Markers

Nilotinib Combined with Multi-Agent Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Interim Results of Korean Adult ALL Working Party Phase 2 Study

Therapeutic Comparision of Surgical Resection Followed by R-CHOP and R-CHOP Alone for Primary Localized Intestinal Diffuse Large B Cell Lymphoma

Early Response to Botezomib Combined Chemotherapy Can Be Helpful for Prediction of Progression Free Survival in Patients with Multiple Myeloma Who Were Ineligible for Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only